Choline's role in maintaining liver function: New evidence for epigenetic mechanisms

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 3, 2013, Pages 339-345

  Mehedint, Mihai G ^a   Zeisel, Steven H ^a  

^a University of North Carolina   (United States)

Author keywords

choline; DNA methylation; epigenetics; fatty liver; liver carcinoma

Indexed keywords

CHOLINE; FOLIC ACID; METHIONINE; METHYL GROUP;

CARCINOGENESIS; DIETARY INTAKE; DNA METHYLATION; DNA POLYMORPHISM; EPIGENETICS; FATTY LIVER; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FUNCTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; REVIEW;

ANIMALS; CHOLINE; DIET; DNA METHYLATION; EPIGENESIS, GENETIC; FATTY LIVER; FOLIC ACID; GENE EXPRESSION; HISTONES; HUMANS; LIVER; LIVER CIRRHOSIS; MODELS, ANIMAL; POLYMORPHISM, GENETIC; S-ADENOSYLMETHIONINE;

RODENTIA;

EID: 84876406606     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283600d46     Document Type: Review

References (89)

1. Zeisel SH. Nutritional genomics: defining the dietary requirement and effects of choline. J Nutr 2011; 141:531-534.
2. Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 2006; 26:229-250.
3. Zeisel SH. Institute of Medicine, National Academy of Sciences USA. Choline. In: Dietary reference intakes for folate, thiamin, riboflavin, niacin, vitamin B12, pantothenic acid, biotin, and choline. Washington, D.C.: National Academy Press; 1998. pp. 390-422.
4. Cho E, Zeisel SH, Jacques P, et al. Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr 2006; 83:905-911.
5. Bidulescu A, Chambless LE, Siega-Riz AM, et al. Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc Disord 2007; 7:20.
6. Bidulescu A, Chambless LE, Siega-Riz AM, et al. Repeatability and measurement error in the assessment of choline and betaine dietary intake: the Atherosclerosis Risk in Communities (ARIC) study. Nutr J 2009; 8:14.
7. Cho E, Willett WC, Colditz GA, et al. Dietary choline and betaine and the risk of distal colorectal adenoma in women. J Natl Cancer Inst 2007; 99:1224-1231.
8. Sentongo TA, Kumar P, Karza K, et al. Whole-blood-free choline and choline metabolites in infants who require chronic parenteral nutrition therapy. J Pediatr Gastroenterol Nutr 2010; 50:194-199.
9. Fischer LM, daCosta K, Kwock L, et al. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr 2007; 85:1275-1285.
10. Resseguie ME, da Costa KA, Galanko JA, et al. Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction. J Biol Chem 2011; 286:1649-1658.
11. Da Costa KA, Kozyreva OG, Song J, et al. Common genetic polymorphisms affect the human requirement for the nutrient choline. FASEB J 2006; 20:1336-1344.
12. Kohlmeier M, da Costa KA, Fischer LM, et al. Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc Natl Acad Sci USA 2005; 102:16025-16030.
13. Sha W, da Costa KA, Fischer LM, et al. Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline. FASEB J 2010; 24:2962-2975.
14. Buchman AL. The addition of choline to parenteral nutrition. Gastroenterology 2009; 137:S119-S128.
15. Hebbard L, George J. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2011; 8:35-44.
16. Pagadala MR, McCullough AJ. The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin Liver Dis 2012; 16:487-504.
17. Cole LK, Vance JE, Vance DE. Phosphatidylcholine biosynthesis and lipo-protein metabolism. Biochim Biophys Acta 2012; 1821:754-761.
18. Fischer LM, da Costa KA, Kwock L, et al. Dietary choline requirements of women: effects of estrogen and genetic variation. Am J Clin Nutr 2010; 92:1113-1119.
19. Corbin KD, Abdelmalek MF, Spencer MD, et al. Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis. FASEB J 2013 [Epub ahead of print]. doi: fj.12-219097
20. Yoshiji H, Yoshii J, Ikenaka Y, et al. Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. J Hepatol 2002; 37:22-30.
21. Shimizu K, Onishi M, Sugata E, et al. Disturbance of DNA methylation patterns in the early phase of hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet in rats. Cancer Sci 2007; 98:1318-1322.
22. Teng YW, Mehedint MG, Garrow TA, et al. Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas. J Biol Chem 2011;286:36258-36267.
23. Zeisel SH, Albright CD, Shin O-K, et al. Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes. Carcinogenesis 1997; 18:731-738.
24. Schrager TF, Newberne PM, Pikul AH, et al. Aflatoxin-DNA adduct formation in chronically dosed rats fed a choline-deficient diet. Carcinogenesis 1990; 11:177-180.
25. Pogribny IP, Shpyleva SI, Muskhelishvili L, et al. Role of DNA damage and alterations in cytosine DNA methylation in rat liver carcinogenesis induced by a methyl-deficient diet. Mutat Res 2009; 669:56-62.
26. Baric I. Inherited disorders in the conversion of methionine to homocysteine. J Inherit Metab Dis 2009; 32:459-471.
27. Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 2006; 174:341-348.
28. Li G, Reinberg D. Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev 2011; 21:175-186.
29. Van Steensel B. Chromatin: constructing the big picture. EMBO J 2011; 30:1885-1895.
30. Fierz B, Muir TW. Chromatin as an expansive canvas for chemical biology. Nat Chem Biol 2012; 8:417-427.
31. Bassols J, Prats-Puig A, Vazquez-Ruiz M, et al. Placental FTO expression relates to fetal growth. Int J Obes (Lond) 2010; 34:1365-1370.
32. Kubicek S, O'Sullivan RJ, August EM, et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 2007; 25:473-481.
33. Loyola A, Tagami H, Bonaldi T, et al. The HP1alpha-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin. EMBO Rep 2009; 10:769-775.
34. Niculescu MD, Craciunescu CN, Zeisel SH. Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J 2006; 20:43-49.
35. Chedin F. The DNMT3 family of mammalian de novo DNA methyltransferases. Prog Mol Biol Transl Sci 2011; 101:255-285.
36. Blusztajn JK, Mellott TJ. Choline nutrition programs brain development via DNA and histone methylation. Cent Nerv Syst Agents Med Chem 2012; 12:82-94.
37. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8:253-262.
38. Fujiki K, Kano F, Shiota K, et al. Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol 2009; 7:38.
39. Esfandiari F, Medici V, Wong DH, et al. Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse. Hepatology 2010; 51:932-941.
40. Pal-Bhadra M, Bhadra U, Jackson DE, et al. Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up-down-regulation of genes by ethanol in hepatocytes. Life Sci 2007; 81:979-987.
41. Lomba A, Milagro FI, Garcia-Diaz DF, et al. Obesity induced by a pair-fed high fat sucrose diet: methylation and expression pattern of genes related to energy homeostasis. Lipids Health Dis 2010; 9:60.
42. Xiong Y, Lei QY, Zhao S, et al. Regulation of glycolysis and gluconeogenesis by acetylation of PKM and PEPCK. Cold Spring Harb Symp Quant Biol 2011; 76:285-289.
43. Plosch T, Gellhaus A, van Straten EM, et al. The liver X receptor (LXR) and its target gene ABCA1 are regulated upon low oxygen in human trophoblast cells: a reason for alterations in preeclampsia? Placenta 2010; 31:910-918.
44. Zhang J, Gong C, Bing Y, et al. Hypermethylation-repressed methionine adenosyltransferase 1A as a potential biomarker for hepatocellular carcinoma. Hepatol Res 2012 [Epub ahead of print]. doi: 10.1111/j.1872-034X.2012. 01099.x
45. Pogribny IP, Tryndyak VP, Bagnyukova TV, et al. Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol 2009; 51:176-186.
46. Kovacheva VP, Mellott TJ, Davison JM, et al. Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression. J Biol Chem 2007; 282:31777-31788.
47. Davison JM, Mellott TJ, Kovacheva VP, et al. Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genesinrat fetal liver and brain. J Biol Chem 2009; 284:1982-1989.
48. Mehedint MG, Niculescu MD, Craciunescu CN, et al. Choline deficiency alters global histone methylation and epigenetic marking at the Re1 site of the calbindin 1 gene. FASEB J 2010; 24:184-195.
49. Estecio MR, Gallegos J, Dekmezian M, et al. SINE retrotransposons cause epigenetic reprogramming of adjacent gene promoters. Mol Cancer Res 2012; 10:1332-1342.
50. Asada K, Kotake Y, Asada R, et al. LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period. J Biomed Biotechnol 2006; 2006:17142.
51. Hitchler MJ, Domann FE. Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radic Biol Med 2009; 47:115-127.
52. Hui JM, Hodge A, Farrell GC, et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004; 40:46-54.
53. Zhou YJ, Li YY, Nie YQ, et al. Influence of polygenetic polymorphisms on the susceptibility to nonalcoholic fatty liver disease of Chinese people. J Gastro-enterol Hepatol 2010; 25:772-777.
54. Annoni G, Weiner FR, Zern MA. Increased transforming growth factor-beta 1 gene expression in human liver disease. J Hepatol 1992; 14:259-264.
55. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991; 324:933-940.
56. Haukeland JW, Damas JK, Konopski Z, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 2006; 44:1167-1174.
57. Esposito K, Pontillo A, Giugliano F, et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 2003; 88:1055-1058.
58. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116:1494-1505.
59. Ito M, Suzuki J, Tsujioka S, et al. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol Res 2007; 37:50-57.
60. Rull A, Rodriguez F, Aragones G, et al. Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis. Cytokine 2009; 48:273-279.
61. Mikael LG, Pancer J, Wu Q, et al. Disturbed one-carbon metabolism causing adverse reproductive outcomes in mice is associated with altered expression of apolipoprotein AI and inflammatory mediators PPARalpha, interferon-gamma, and interleukin-10. J Nutr 2012; 142:411-418.
62. Berres ML, Koenen RR, Rueland A, et al. Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest 2010; 120:4129-4140.
63. Desai MS, Mariscalco MM, Tawil A, et al. Atherogenic diet-induced hepatitis is partially dependent on murine TLR4. J Leukoc Biol 2008; 83:1336-1344.
64. Wu H, Ghosh S, Perrard XD, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007; 115:1029-1038.
65. Jarrar MH, Baranova A, Collantes R, et al. Adipokines and cytokines in nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2008; 27:412-421.
66. Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin Liver Dis 2004; 8:639-671; xi.
67. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr 1994; 14:269-296.
68. Koca SS, Bahcecioglu IH, Poyrazoglu OK, et al. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the nonalcoholic steatohepatitis induced by methionine-and choline-deficient diet. Inflammation 2008; 31:91-98.
69. Bian EB, Huang C, Ma TT, et al. DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol 2012; 264:13-22.
70. Tomita K, Teratani T, Suzuki T, et al. p53/p66Shc-mediated signaling contributes to the progression of nonalcoholic steatohepatitis in humans and mice. J Hepatol 2012; 57:837-843.
71. Gressner AM, Weiskirchen R, Breitkopf K, et al. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002; 7:d793-d807.
72. Liu Y, Wen XM, Lui EL, et al. Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258. Lab Invest 2009; 89:1152-1160.
73. Mann J, Chu DC, Maxwell A, et al. MeCP2 controls anepigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 2010; 138:705-714; 714.e701-714.e704.
74. Tao H, Huang C, Yang JJ, et al. MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats. Toxicology 2011; 290:327-333.
75. Zeybel M, Hardy T, Wong YK, et al. Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat Med 2012; 18:1369-1377.
76. Herceg Z, Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat Res 2011; 727:55-61.
77. Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett 2012 [Epub ahead of print]. doi: S0304-3835(12)00082-1 [pii]
78. Poirier LA. Methyl group deficiency in hepatocarcinogenesis. Drug Metab Rev 1994; 26:185-199.
79. Christman JK. Lipotrope deficiency and persistent changes in DNA methyla-tion. Lipotrope deficiency and DNA methylation. Adv Exp Med Biol 1995; 375:97-106.
80. Tsujiuchi T, Tsutsumi M, Sasaki Y, et al. Hypomethylation of CpG sites and c-myc gene overexpression in hepatocellular carcinomas, but not hyperplastic nodules, induced by a choline-deficient L-amino acid-defined diet in rats. Jpn J Cancer Res 1999; 90:909-913.
81. Christman JK, Sheikhnejad G, Dizik M, et al. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 1993; 14:551-557.
82. Lu SC, Alvarez L, Huang ZZ, et al. Methionineadenosyl transferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci USA 2001; 98:5560-5565.
83. Tomasi ML, Iglesias-Ara A, Yang H, et al. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcino-genesis. Gastroenterology 2009; 136:1025-1036.
84. Ko KS, Tomasi ML, Iglesias-Ara A, et al. Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology 2010; 52:2096-2108.
85. Contos JJ, Ishii I, Chun J. Lysophosphatidic acid receptors. Mol Pharmacol 2000; 58:1188-1196.
86. Fang X, Schummer M, Mao M, et al. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta 2002; 1582:257-264.
87. Selvy PE, Lavieri RR, Lindsley CW, et al. Phospholipase D: enzymology, functionality, and chemical modulation. Chem Rev 2011; 111:6064-6119.
88. Okabe K, Hayashi M, Yoshida I, et al. Distinct DNA methylation patterns of lysophosphatidic acid receptor genes during rat hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet. Arch Toxicol 2011; 85:1303-1310.
89. Obo Y, Yamada T, Furukawa M, et al. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors. Mutat Res 2009; 660:47-50.